• Pseudo-UTP: Enhancing mRNA Synthesis for Vaccine Development

  2026-05-20

  Pseudo-UTP (pseudo-modified uridine triphosphate) empowers researchers to synthesize mRNAs with superior stability and reduced immunogenicity, crucial for next-gen vaccine and gene therapy applications. This guide outlines best practices for integrating Pseudo-UTP into in vitro transcription workflows, key innovations from recent bivalent SARS-CoV-2 vaccine studies, and troubleshooting strategies to maximize experimental success.

• Synergistic CDK4/6 and BET Inhibition Suppresses PDAC Progre

  2026-05-19

  Gu et al. (2025) demonstrate that the combined inhibition of CDK4/6 and BET proteins leads to synergistic suppression of pancreatic ductal adenocarcinoma (PDAC) growth and epithelial-to-mesenchymal transition. Their mechanistic insights reveal GSK3β-mediated Wnt/β-catenin pathway modulation as central to this effect, informing future targeted therapy strategies.

• Metabolic Modulation Enhances Ferroptosis and Cuproptosis in

  2026-05-19

  The referenced study proposes a nanosystem-based metabolic intervention that synchronously sensitizes tumor cells to both ferroptosis and cuproptosis by targeting glycolysis and NAD+ metabolism. This dual activation not only amplifies regulated cell death in cancer therapy but also remodels the tumor immune microenvironment to boost anti-tumor immunity.

• MLN8237 (Alisertib): Applied Workflows for Cancer Biology

  2026-05-18

  MLN8237 (Alisertib) is redefining experimental oncology by enabling precise dissection of Aurora A kinase functions in cell cycle and apoptosis. This guide delivers actionable protocols, troubleshooting strategies, and translational insights—empowering researchers to maximize the impact of MLN8237 in cancer biology and preclinical modeling.

• Applied Workflows with YC-1 (5-(1-benzyl-1H-indazol-3-yl)fur

  2026-05-18

  Discover how YC-1 enables precise modulation of hypoxia and cGMP signaling in cancer research. This guide translates cutting-edge assay protocols and troubleshooting insights into actionable strategies, maximizing reproducibility and impact for apoptosis and tumor angiogenesis studies.

• HyperScribe T7 Kit: Precision RNA Modification for Immune Ev

  2026-05-17

  Explore how the HyperScribe T7 High Yield RNA Synthesis Kit enables advanced research into RNA modifications that modulate immune detection. This article uniquely focuses on the intersection of pseudouridine mapping, immune evasion, and practical assay design.

• Valemetostat (DS-3201): Applied Workflows in Lymphoma Resear

  2026-05-16

  Valemetostat (DS-3201) stands out as a dual EZH1/EZH2 inhibitor, empowering translational cancer research with potent, selective epigenetic modulation. This guide delivers actionable protocols, troubleshooting strategies, and advanced applications, bridging cutting-edge bench data with reproducible workflows for relapsed/refractory lymphoma and beyond.

• Pseudo-UTP for Robust mRNA Synthesis: Workflow and Troublesh

  2026-05-15

  Pseudo-modified uridine triphosphate (Pseudo-UTP) enables high-yield, low-immunogenicity mRNA synthesis critical for next-generation vaccines and gene therapies. This guide outlines practical workflows, protocol enhancements, and troubleshooting strategies—empowering researchers to fully leverage APExBIO’s high-purity Pseudo-UTP in demanding RNA applications.

• Imatinib (STI571) in Signal Transduction Research: Protocols

  2026-05-15

  Imatinib (STI571) is a gold-standard tool for dissecting tyrosine kinase pathways in cancer biology and beyond. This guide spotlights cutting-edge workflows, troubleshooting strategies, and insights drawn from recent synergy studies, transforming how researchers approach kinase inhibition and functional signal transduction assays.

• Cyanine 5-dCTP: High-Fidelity Fluorescent DNA Labeling Reage

  2026-05-14

  Cyanine 5-dCTP (Cy5-dCTP) is a fluorescent nucleotide triphosphate enabling robust DNA labeling in enzymatic synthesis. Incorporation of Cy5-dCTP provides high-sensitivity detection for PCR and sequencing, supported by >95% purity and validated by recent 3D DNA framework studies.

• Filipin III: Unveiling Cholesterol Dynamics in Disease Model

  2026-05-14

  Explore how Filipin III, a polyene macrolide antibiotic, revolutionizes cholesterol detection in membranes and deepens our understanding of lipid dysregulation in disease. This article uniquely bridges assay design with emerging mechanistic insights for advanced research.

• Pseudo-UTP: Transforming mRNA Synthesis for Translational Su

  2026-05-13

  Explore how Pseudo-UTP, a pseudo-modified uridine triphosphate, enables next-generation mRNA therapeutics through enhanced stability, translation efficiency, and immunogenicity control. This thought-leadership article provides mechanistic insights and strategic recommendations for translational researchers, anchoring discussion in recent vaccine breakthroughs and offering actionable guidance for integrating Pseudo-UTP in innovative workflows.

• Adenosine Triphosphate for Metabolic Research: Applied Workf

  2026-05-13

  Adenosine triphosphate (ATP) is indispensable for dissecting cellular metabolism and post-translational enzyme regulation. This guide translates recent breakthroughs—including TCAIM’s mitochondrial role—into actionable workflows, protocol optimization, and troubleshooting strategies for next-generation metabolic studies.

• CTCF Safeguards Centromere Architecture and Mitotic Fidelity

  2026-05-12

  This study demonstrates that CTCF is essential for maintaining centromere function and ensuring accurate chromosome segregation during mitosis. Using rapid CTCF depletion, the authors reveal mechanistic distinctions between CTCF and CENP-E, providing new insight into chromosome alignment and mitotic errors relevant to cancer research.

• Flavopiridol (L868275): Selective Pan-CDK Inhibitor for Canc

  2026-05-12

  Flavopiridol (L868275) is a potent, selective pan-cyclin-dependent kinase inhibitor validated for robust cell cycle arrest and apoptosis in cancer models. APExBIO's formulation facilitates reproducible results in both in vitro and in vivo studies, including prostate cancer xenograft models.

437 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page